Elevance Health, Inc.
For the period ended Mar 31, 2026. Filed Apr 22, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 22, 2026
ELV$429.65+2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income (Unaudited) for the and
Consolidated Statements of Income
| Three Months Ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| (In millions, except per share data) | ||
| Revenues | ||
| Premiums | $41,024 | $40,887 |
| Product revenue | 6,225 | 5,809 |
| Service fees | 2,245 | 2,069 |
| Total operating revenue | 49,494 | 48,765 |
| Net investment income | 765 | 590 |
| Net losses on financial instruments | (78) | (464) |
| Total revenues | 50,181 | 48,891 |
| Expenses | ||
| Benefit expense | 35,615 | 35,312 |
| Cost of products sold | 5,463 | 4,983 |
| Operating expense | 6,330 | 5,300 |
| Interest expense | 357 | 344 |
| Amortization of other intangible assets | 112 | 155 |
| Total expenses | 47,877 | 46,094 |
| Income before income tax expense | 2,304 | 2,797 |
| Income tax expense | 544 | 613 |
| Net income | 1,760 | 2,184 |
| Net loss (gain) attributable to noncontrolling interests | 4 | (1) |
| Shareholders’ net income | $1,764 | $2,183 |
| Shareholders’ net income per share | ||
| Basic | $8.03 | $9.64 |
| Diluted | $8.00 | $9.61 |
| Dividends per share | $1.72 | $1.71 |
-3-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.